58721-74-7 Usage
Chemical structure
A complex organic compound with a fused ring structure consisting of a pyrroloquinoline core with five methyl groups and a trifluoromethyl group attached to it.
Family
A member of the quinolinone family, which is a group of organic compounds that contain a quinoline ring fused to another ring.
Structural complexity
Characterized by its high level of structural complexity due to the presence of multiple fused rings and functional groups.
Potential applications
May have potential applications in pharmaceutical or material science research due to its unique structure and properties.
Further study
Further study and analysis are necessary to fully understand its potential uses and effects.
Molecular weight
Approximately 341.38 g/mol
Appearance
The appearance of 1,2,3,8-tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one is not specified in the provided material, but it is likely a solid due to its complex structure.
Solubility
The solubility of 1,2,3,8-tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one is not specified in the provided material, but it may be soluble in organic solvents such as ethanol or dimethyl sulfoxide (DMSO) due to its nonpolar nature.
Stability
The stability of 1,2,3,8-tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one is not specified in the provided material, but it may be sensitive to light, heat, or moisture due to its complex structure and the presence of a trifluoromethyl group.
Reactivity
The reactivity of 1,2,3,8-tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one is not specified in the provided material, but it may be reactive towards nucleophiles, electrophiles, or other reactive species due to the presence of its quinolinone core and other functional groups.
Synthesis
The synthesis of 1,2,3,8-tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one is not described in the provided material, but it likely involves multiple steps and the use of various reagents and reaction conditions to form the fused ring structure and attach the functional groups.
Analysis
The analysis of 1,2,3,8-tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one may involve techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, or elemental analysis to confirm its structure and purity.
Safety
The safety profile of 1,2,3,8-tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one is not specified in the provided material, but it may have potential hazards due to its complex structure and the presence of a trifluoromethyl group. Proper handling and safety precautions should be taken when working with 1,2,3,8-tetrahydro-1,2,3,3,8-pentamethyl-5-(trifluoromethyl)-7H-pyrrolo[3,2-g]quinolin-7-one.
Check Digit Verification of cas no
The CAS Registry Mumber 58721-74-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,7,2 and 1 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 58721-74:
(7*5)+(6*8)+(5*7)+(4*2)+(3*1)+(2*7)+(1*4)=147
147 % 10 = 7
So 58721-74-7 is a valid CAS Registry Number.
InChI:InChI=1/C17H19F3N2O/c1-9-16(2,3)12-6-10-11(17(18,19)20)7-15(23)22(5)13(10)8-14(12)21(9)4/h6-9H,1-5H3
58721-74-7Relevant academic research and scientific papers
New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone
Edwards, James P.,West, Sarah J.,Pooley, Charlotte L. F.,Marschke, Keith B.,Farmer, Luc J.,Jones, Todd K.
, p. 745 - 750 (2007/10/03)
A series of 2(1H)-pyrrolidino[3,2-g]quinolinones was prepared and tested for the ability to modulate the transcriptional activity of the human androgen receptor (hAR). The parent compound, 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g]quinolinone, displayed moderate interaction with hAR, but more substituted analogues, particularly 6,7-disubstituted compounds, were potent hAR agonists in vitro.
